Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men

Obesity
Kazushi Tsuda

Abstract

Abnormalities in physicochemical properties of the cell membranes may underlie the defects that are strongly linked to hypertension. Recent evidence indicates that adiponectin may have protective effects against cardiovascular diseases. The purpose of the present study was to assess the possible link between plasma adiponectin and membrane fluidity in normotensive (NT) and hypertensive (HT) men. We measured the membrane fluidity (a reciprocal value of membrane microviscosity) of erythrocytes in NT and HT men by using an electron paramagnetic resonance and spin-labeling method. The order parameter (S) for the spin label agent (5-nitroxide stearate) and the peak height ratio (h0/h(-1)) for 16-nitroxide stearate in the electron paramagnetic resonance spectra of erythrocytes were significantly higher in HT men than in NT men, indicating that membrane fluidity of erythrocytes was decreased in HT men compared with NT men. Both of plasma adiponectin and nitric oxide (NO) metabolite levels were significantly lower in HT men than in NT men. The plasma adiponectin levels were correlated with plasma NO metabolites. The S and the h0/h(-1) of erythrocytes were inversely correlated with the plasma adiponectin and NO metabolite levels, indica...Continue Reading

References

Feb 1, 1978·The Journal of Clinical Investigation·B SatoF H Tyler
Jul 5, 1990·The New England Journal of Medicine·J A PanzaS E Epstein
Jan 1, 1980·Clinical and Experimental Hypertension : CHE·Y YamoriA Ooshima
Sep 6, 1994·Chemistry and Physics of Lipids·P K KinnunenP Mustonen
Dec 1, 1996·American Journal of Hypertension·B C Jubelin, J L Gierman
Apr 7, 1999·American Journal of Hypertension·J ZichaM A Devynck
Aug 17, 2000·Nitric Oxide : Biology and Chemistry·P Muriel, G Sandoval
Jan 9, 2003·American Journal of Hypertension·Marcin AdamczakYuji Matsuzawa
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Masahiro KumadaUNKNOWN Osaka CAD Study Group. Coronary artery disease
Mar 7, 2003·American Journal of Hypertension·Kazushi Tsuda, Ichiro Nishio
May 6, 2003·Biochimica Et Biophysica Acta·A G Lee
Jul 16, 2003·Hypertension·Noriyuki OuchiYuji Matsuzawa
Aug 29, 2003·The Journal of Biological Chemistry·Hui ChenMichael J Quon
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·K C B TanK S L Lam
May 5, 2004·Hypertension·Yoshio IwashimaToshio Ogihara

❮ Previous
Next ❯

Citations

Aug 22, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Katsuko MiyanagaTsutomu Kazumi
Aug 13, 2010·Diabetes Research and Clinical Practice·D Simmons
Nov 6, 2017·Clinical and Experimental Nephrology·Hirokazu HondaAkira Hishida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.